Top-News

Die Bullen starten durch – spektakuläre Kursgewinne möglich(Anzeige)

Handeln

Zelira Therapeutics News


0,426 €		-3,18%	-0,014 €

30.04.24 21:46:04 Berlin

aktualisieren | Orderbuch | Mehr Kurse »

WKN: A2AS5H

ISIN: AU000000ZLD1

US-Symbol: ZLDAF

Typ: Aktie

Zelira Therapeutics News

20.09.22 - PR Newswire

Zelira Therapeutics Launches ZYRAYDI™ B2B Technology to Create Pharma-grade Cannabis Capsules & Tablets for Global Markets

Zelira Therapeutics Launches ZYRAYDI™ B2B Technology to Create Pharma-grade Cannabis Capsules & Tablets for Global Markets PR Newswire

21.07.22 - PR Newswire

Zelira's Zenivol™, the World's First Clinically Validated Cannabinoid Medication for Insomnia, Achieves Regulatory Approval in Germany

Zelira's Zenivol™, the World's First Clinically Validated Cannabinoid Medication for Insomnia, Achieves Regulatory Approval in Germany PR Newswire

23.09.21 - PR Newswire

Zelira™ Launches RAF FIVE™ Acne Treatment Products Through Its Dermatology Focused Subsidiary

Zelira™ Launches RAF FIVE™ Acne Treatment Products Through Its Dermatology Focused Subsidiary PR Newswire

15.12.20 - PR Newswire

Zelira Therapeutics Expands HOPE™ Distribution in the US Through Licensing Agreement with Alternative Solutions in Washington DC

Zelira Therapeutics Expands HOPE™ Distribution in the US Through Licensing Agreement with Alternative Solutions in Washington DC Agreement Signifies HOPE's Largest ...

30.08.06 - Aktiencheck

Gleneagle Gold chancenreich - Der Aktionär

Newssuche

Videos

30.04.24 -9,41%

Technical Trading: Sojabohnen Long bis Juli

Sojabohnen Long Typ: Turbo Open End WKN: VX41AH Hebel: 5 Laufzeit: OpenEnd Einstieg: Market ... Mehr »

Saubere Energie

Milliardärsinvestoren sehen enorme Chancen in der alternativen Energie der nächsten Generation
weiterlesen»

Anzeige